| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| Gona-1,5,7,9,11,13-hexaen-17-one,3,4-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-,(3a,4b)-(?脿)- | 3,4,15,16-tetrahydro-trans-3,4-bis<(tert-butyldimethylsilyl)oxy>cyclopenta<a>phenanthren-17-one | 143216-83-5 | C29H42O3Si2 |
| Gona-1,3,5,7,9-pentaene-11,17-dione,(13a)-(?脿)-(9CI) | 11,17-Dioxo-14β-gonapentaen-1,3,5(10),6,8 | 23462-83-1 | C17H14O2 |
| Gona-1,3,5,7,9-pentaen-11-one,17-hydroxy-,(14b,17a)-(?脿)-(9CI) | 14beta-Gona-1,3,5,7,9-pentaen-11-one, 17alpha-hydroxy-, (+-)- | 23462-86-4 | C17H16O2 |
| Gona-1,3,5(10),8,14-pentaen-17-one,13-ethyl-3-methoxy-,(?脿)-(8CI,9CI) | (+/-)-13-ethyl-3-methoxygona-1,3,5(10),8,14-pentaen-17-one | 848-07-7 | C20H22O2 |
| Gm1-低聚糖 | G(M1)-Oligosaccharide | 85373-04-2 | C37H62N2O29 |
| Gly-His 盐酸盐 水合物 | 2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoic acid;hydrochloride | 3486-76-8 | C8H13ClN4O3 |
| Givinostat盐酸盐 | diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride | 199657-29-9 | C24H27N3O4*ClH |
| Girards试剂D | N,N-Dimethylglycine Hydrazide Dihydrochloride | 5787-71-3 | C4H13Cl2N3O |
| GinsenoyneK;(3R,10S,8E)-10-氢过氧-1,8-十七碳二烯-4,6-二炔-3-醇 | (3R,8E,10S)-10-Hydroperoxyheptadeca-1,8-dien-4,6-diyn-3-OL | 141947-42-4 | C17H24O3 |
| Gg4去唾液酸-低聚糖 | Gangliotetraose | 75645-24-8 | C26H45NO21 |
| Garg5-溴-3,4-吡啶炔前体 | 5-bromo-4-(trimethylsilyl)pyridin-3-yl triflate | 1413439-82-3 | C9H11BrF3NO3SSi |
| Gardenine;[2aS-(2aalpha,4aalpha,7aalpha,7balpha)]-2,2a,4a,7,7a,7b-六氢-2a-羟基-1-氧杂-7-氮杂环戊并[cd]茚-5-羧酸甲酯 | Gardenine | 139682-36-3 | C11H13NO4 |
| GarcinoneC;1,3,6,7-四羟基-8-(3-羟基-3-甲基丁基)-2-(3-甲基-2-丁烯-1-基)-9H-呫吨-9-酮 | garcinone C | 76996-27-5 | C23H26O7 |
| Gamma-蜡烷 | gammacerane | 559-65-9 | C30H52 |
| Gamma-L-谷氨酰-Beta-萘酰胺 | (S)-2-Amino-5-(naphthalen-2-ylamino)-5-oxopentanoic acid | 14525-44-1 | C15H16N2O3 |
| Gamma,2-二氨基苯丙醇 | 3-Amino-3-(2-aminophenyl)propan-1-ol | 886364-15-4 | C9H14N2O |
| Galili抗原五糖 | Lacto-N-difucohexose II | 62258-12-2 | C38H65NO29 |
| GZD824甲磺酸盐 | GZD824 Dimesylate | 1421783-64-3 | C31H35F3N6O7S2 |
| GYKI52466,盐酸盐 | GYKI 52466 hydrochloride | 192065-56-8 | C17H16ClN3O2 |
| GYKI-53655水合物 | 5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide;hydron;chloride | 143692-48-2 | C19H21ClN4O3 |
| GW627368X抑制剂 | N-(benzenesulfonyl)-2-[4-(4,9-diethoxy-3-oxo-1H-benzo[f]isoindol-2-yl)phenyl]acetamide | 439288-66-1 | C30H28N2O6S |
| GW501516甲酯 | methyl [2-methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]thiazol-5-yl]methyl]sulfanyl]peroxy]acetate | 317318-69-7 | C22H20F3NO3S2 |
| GW405833盐酸盐 | (2,3-dichlorophenyl)(5-methoxy-2-methyl-3-(2-morpholinoethyl)-1H-indol-1-yl)methanone | 180002-83-9 | C23H24Cl2N2O3 |
| GTx-134; 2-[4-[[(2R)-3-(2,4-二甲基苯氧基)-2-羟基丙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-6,7-二氢-6-[1-[2-(甲磺酰基)乙基]-4-哌啶基]吡咯并[3,4-f]苯并咪唑-5(3H)-酮 | 2-{4-[(R)-3-(2,4-dimethylphenoxy)-2-hydroxypropylamino]-2-oxo-1,2-dihydropyridin-3-yl}-6-[1-(2-methanesulfonylethyl)piperidin-4-yl]-6,7-dihydro-3H-1,3,6-triaza-s-indacen-5-one | 1008448-19-8 | C33H40N6O6S |
| GSKPERK抑制剂 | 1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone | 1337531-89-1 | C24H19F4N5O |
| GSK789472盐酸盐 | 1-Phenyl-3-(piperidin-2-ylmethyl)imidazolidin-2-one hydrochloride | 1257326-24-1 | C15H22ClN3O |
| GSK2636771甲酯 | methyl 2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylate | 1372540-24-3 | C23H24F3N3O3 |
| GSK256066三氟乙酸盐 | GSK256066 2,2,2-trifluoroacetic acid | 1415560-64-3 | C29H27F3N4O7S |
| GSK2334470游离态 | GKS2334470 | 1227911-45-6 | C25H34N8O |
| GSK2193874游离态 | GSK2193874 | 1336960-13-4 | C37H38BrF3N4O |
| GSK-3抑制剂(LY2090314) | 7-(2,5-dihydro-4-imidazo[1,2-a]pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo[3,2,1-jk][1,4]benzodiazepine | 603288-22-8 | C28H25FN6O3 |
| GSK-3beta 抑制剂 XI | GSK-3b Inhibitor XI | 626604-39-5 | C18H15N5O3 |
| GSK-2110183C无结构图 | afuresertib | 1047644-62-1 | C18H17Cl2FN4OS |
| GSK 525762A; (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺 | I-BET762 | 1260907-17-2 | C22H22ClN5O2 |
| GSK 189254; 6-[(3-环丁基-2,3,4,5-四氢-1H-3-苯并氮杂卓-7-基)氧基]-N-甲基-3-吡啶甲酰胺盐酸盐 | [3H]-GSK189254 | 945493-87-8 | C21H25N3O2*ClH |
| GSK 1292263 盐酸盐 | 5-[({1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methyl)oxy]-2-[4-(methylsulfonyl)phenyl]pyridine hydrochloride | 1032824-54-6 | C23H28N4O4S*ClH |
| GSK 1059615; (5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 | GSK1059615 | 958852-01-2 | C18H11N3O2S |
| GRANULAR BLUE 粒蓝相似物 | 2-<4-(4-Amidinophenoxy)phenyl>indol-6-carboxamidin-dihydrochlorid | 55453-00-4 | C22H19N5O*2ClH |
| GR 127935盐酸盐 | N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-carboxamide | 148672-13-3 | C29H31N5O3 |
| GPR84拮抗剂8 | 2-([1,4]dioxan-2-ylmethoxy)-9-(pyridin-2-ylmethoxy)-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one | 1445846-30-9 | C23H23N3O5 |
| GPR109A受体激动剂(MK-0354) | MK-0354 | 851776-28-8 | C7H8N6 |
| GNF179代谢物 | 2-(4-Fluorophenyl)-8,8-dimethyl-5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine | 1310455-86-7 | C14H16FN3 |
| GNE-495游离态 | 8-amino-N-(1-(cyclopropanecarbonyl)azetidin-3-yl)-2-(3-fluorophenyl)-1,7-naphthyridine-5-carboxamide | 1449277-10-4 | C22H20FN5O2 |
| GNE-477抑制剂 | GNE-477 | 1032754-81-6 | C21H28N8O3S2 |
| GNE-0877抑制剂 | 2-methyl-2-(3-methyl-4-((4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)propanenitrile | 1374828-69-9 | C14H16F3N7 |
| GMD-C16-二聚体 | GMD-C16-dimer | 1043569-41-0 | C72H108N6O16 |
| GM1-五糖 | LS-tetrasaccharide a | 52659-37-7 | C37H62N2O29 |
| GLYX13抑制剂 | Glyx-13 | 117928-94-6 | C18H31N5O6 |
| GLPG0187,一种广谱的INTEGRIN受体拮抗剂,具有抗肿瘤活性 | L-Alanine, 3-((2,5-dimethyl-6-(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1-piperidinyl)-4-pyrimidinyl)amino)-N-((4-methoxyphenyl)sulfonyl) | 1320346-97-1 | C29H37N7O5S |
| GLPG-0634 中间体 | N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | 1142943-96-1 | C10H9BrN4O |